Diabordo, Judelyn D.
HRN: 05-08-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2025
CEFUROXIME 1.5GM (VIAL)
10/28/2025
10/29/2025
IVTT
1.5g
Q8h
UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes